請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/78138
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 陳彥榮 | |
dc.contributor.author | Chieh-Ning Wen | en |
dc.contributor.author | 文婕寧 | zh_TW |
dc.date.accessioned | 2021-07-11T14:43:28Z | - |
dc.date.available | 2021-10-14 | |
dc.date.copyright | 2016-10-14 | |
dc.date.issued | 2016 | |
dc.date.submitted | 2016-08-11 | |
dc.identifier.citation | Akhurst, B., Croager, E.J., Farley-Roche, C.A., Ong, J.K., Dumble, M.L., Knight, B., and Yeoh, G.C. (2001). A modified choline-deficient, ethionine-supplemented diet protocol effectively induces oval cells in mouse liver. Hepatology 34, 519-522.
Apte, U., Thompson, M.D., Cui, S., Liu, B., Cieply, B., and Monga, S.P. (2008). Wnt/beta-catenin signaling mediates oval cell response in rodents. Hepatology 47, 288-295. Bogaerts, E., Heindryckx, F., Devisscher, L., Paridaens, A., Vandewynckel, Y.P., Van den Bussche, A., Verhelst, X., Libbrecht, L., van Grunsven, L.A., Geerts, A., et al. (2015). Time-dependent effect of hypoxia on tumor progression and liver progenitor cell markers in primary liver tumors. PLoS One 10, e0119555. Boulter, L., Govaere, O., Bird, T.G., Radulescu, S., Ramachandran, P., Pellicoro, A., Ridgway, R.A., Seo, S.S., Spee, B., Van Rooijen, N., et al. (2012). Macrophage-derived Wnt opposes Notch signaling to specify hepatic progenitor cell fate in chronic liver disease. Nat Med 18, 572-579. Cannito, S., Paternostro, C., Busletta, C., Bocca, C., Colombatto, S., Miglietta, A., Novo, E., and Parola, M. (2014). Hypoxia, hypoxia-inducible factors and fibrogenesis in chronic liver diseases. Histology and histopathology 29, 33-44. Chen, Y., Wong, P.P., Sjeklocha, L., Steer, C.J., and Sahin, M.B. (2012). Mature hepatocytes exhibit unexpected plasticity by direct dedifferentiation into liver progenitor cells in culture. Hepatology 55, 563-574. Clevers, H. (2006). Wnt/beta-catenin signaling in development and disease. Cell 127, 469-480. Dolle, L., Theise, N.D., Schmelzer, E., Boulter, L., Gires, O., and van Grunsven, L.A. (2015). EpCAM and the biology of hepatic stem/progenitor cells. Am J Physiol Gastrointest Liver Physiol 308, G233-250. Epstein, A.C.R., Gleadle, J.M., McNeill, L.A., Hewitson, K.S., O'Rourke, J., Mole, D.R., Mukherji, M., Metzen, E., Wilson, M.I., Dhanda, A., et al. (2001). C. elegans EGL-9 and Mammalian Homologs Define a Family of Dioxygenases that Regulate HIF by Prolyl Hydroxylation. Cell 107, 43-54. Fausto, N. (2004). Liver regeneration and repair: hepatocytes, progenitor cells, and stem cells. Hepatology 39, 1477-1487. Furuyama, K., Kawaguchi, Y., Akiyama, H., Horiguchi, M., Kodama, S., Kuhara, T., Hosokawa, S., Elbahrawy, A., Soeda, T., Koizumi, M., et al. (2011). Continuous cell supply from a Sox9-expressing progenitor zone in adult liver, exocrine pancreas and intestine. Nat Genet 43, 34-41. Gonzalez, B., Denzel, S., Mack, B., Conrad, M., and Gires, O. (2009). EpCAM is involved in maintenance of the murine embryonic stem cell phenotype. Stem Cells 27, 1782-1791. Heindryckx, F., Kuchnio, A., Casteleyn, C., Coulon, S., Olievier, K., Colle, I., Geerts, A., Libbrecht, L., Carmeliet, P., and Van Vlierberghe, H. (2012). Effect of prolyl hydroxylase domain-2 haplodeficiency on the hepatocarcinogenesis in mice. J Hepatol 57, 61-68. Hu, M., Kurobe, M., Jeong, Y.J., Fuerer, C., Ghole, S., Nusse, R., and Sylvester, K.G. (2007). Wnt/beta-catenin signaling in murine hepatic transit amplifying progenitor cells. Gastroenterology 133, 1579-1591. Huch, M., Dorrell, C., Boj, S.F., van Es, J.H., Li, V.S., van de Wetering, M., Sato, T., Hamer, K., Sasaki, N., Finegold, M.J., et al. (2013). In vitro expansion of single Lgr5+ liver stem cells induced by Wnt-driven regeneration. Nature 494, 247-250. Itoh, T., Kamiya, Y., Okabe, M., Tanaka, M., and Miyajima, A. (2009). Inducible expression of Wnt genes during adult hepatic stem/progenitor cell response. FEBS Lett 583, 777-781. Itoh, T., and Miyajima, A. (2014). Liver regeneration by stem/progenitor cells. Hepatology 59, 1617-1626. Jaakkola, P., Mole, D.R., Tian, Y.-M., Wilson, M.I., Gielbert, J., Gaskell, S.J., Kriegsheim, A.v., Hebestreit, H.F., Mukherji, M., Schofield, C.J., et al. (2001). Targeting of HIF-α to the von Hippel-Lindau Ubiquitylation Complex by O2-Regulated Prolyl Hydroxylation. Science 292, 468-472. Jeliazkova, P., Jors, S., Lee, M., Zimber-Strobl, U., Ferrer, J., Schmid, R.M., Siveke, J.T., and Geisler, F. (2013). Canonical Notch2 signaling determines biliary cell fates of embryonic hepatoblasts and adult hepatocytes independent of Hes1. Hepatology 57, 2469-2479. Lammi, L., Arte, S., Somer, M., Jarvinen, H., Lahermo, P., Thesleff, I., Pirinen, S., and Nieminen, P. (2004). Mutations in AXIN2 cause familial tooth agenesis and predispose to colorectal cancer. Am J Hum Genet 74, 1043-1050. Lee, U.E., and Friedman, S.L. (2011). Mechanisms of hepatic fibrogenesis. Best Pract Res Clin Gastroenterol 25, 195-206. Lehwald, N., Tao, G.Z., Jang, K.Y., Sorkin, M., Knoefel, W.T., and Sylvester, K.G. (2011). Wnt-beta-catenin signaling protects against hepatic ischemia and reperfusion injury in mice. Gastroenterology 141, 707-718, 718 e701-705. Litvinov, S.V., Balzar, M., Winter, M.J., Bakker, H.A., Briaire-de Bruijn, I.H., Prins, F., Fleuren, G.J., and Warnaar, S.O. (1997). Epithelial cell adhesion molecule (Ep-CAM) modulates cell-cell interactions mediated by classic cadherins. The Journal of cell biology 139, 1337-1348. Liu, L., Zhu, X.D., Wang, W.Q., Shen, Y., Qin, Y., Ren, Z.G., Sun, H.C., and Tang, Z.Y. (2010). Activation of beta-catenin by hypoxia in hepatocellular carcinoma contributes to enhanced metastatic potential and poor prognosis. Clin Cancer Res 16, 2740-2750. Logan, C.Y., and Nusse, R. (2004). The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol 20, 781-810. Lowry, W.E., Blanpain, C., Nowak, J.A., Guasch, G., Lewis, L., and Fuchs, E. (2005). Defining the impact of beta-catenin/Tcf transactivation on epithelial stem cells. Genes Dev 19, 1596-1611. Maetzel, D., Denzel, S., Mack, B., Canis, M., Went, P., Benk, M., Kieu, C., Papior, P., Baeuerle, P.A., Munz, M., et al. (2009). Nuclear signalling by tumour-associated antigen EpCAM. Nat Cell Biol 11, 162-171. Mathieu, J., Zhang, Z., Zhou, W., Wang, A.J., Heddleston, J.M., Pinna, C.M., Hubaud, A., Stadler, B., Choi, M., Bar, M., et al. (2011). HIF induces human embryonic stem cell markers in cancer cells. Cancer Res 71, 4640-4652. Mazumdar, J., O'Brien, W.T., Johnson, R.S., LaManna, J.C., Chavez, J.C., Klein, P.S., and Simon, M.C. (2010). O2 regulates stem cells through Wnt/beta-catenin signalling. Nat Cell Biol 12, 1007-1013. Michalopoulos, G.K. (2014). The liver is a peculiar organ when it comes to stem cells. Am J Pathol 184, 1263-1267. Michalopoulos, G.K., Barua, L., and Bowen, W.C. (2005). Transdifferentiation of rat hepatocytes into biliary cells after bile duct ligation and toxic biliary injury. Hepatology 41, 535-544. Michelotti, G.A., Xie, G., Swiderska, M., Choi, S.S., Karaca, G., Kruger, L., Premont, R., Yang, L., Syn, W.K., Metzger, D., et al. (2013). Smoothened is a master regulator of adult liver repair. J Clin Invest 123, 2380-2394. Miyajima, A., Tanaka, M., and Itoh, T. (2014). Stem/progenitor cells in liver development, homeostasis, regeneration, and reprogramming. Cell Stem Cell 14, 561-574. Miyaoka, Y., Ebato, K., Kato, H., Arakawa, S., Shimizu, S., and Miyajima, A. (2012). Hypertrophy and unconventional cell division of hepatocytes underlie liver regeneration. Curr Biol 22, 1166-1175. Moczydlowska, J., Miltyk, W., Hermanowicz, A., Lebensztejn, D.M., Palka, J.A., and Debek, W. (2016). HIF-1 alpha as a Key Factor in Bile Duct Ligation-Induced Liver Fibrosis in Rats. J Invest Surg, 1-6. Mohyeldin, A., Garzon-Muvdi, T., and Quinones-Hinojosa, A. (2010). Oxygen in stem cell biology: a critical component of the stem cell niche. Cell Stem Cell 7, 150-161. Munz, M., Baeuerle, P.A., and Gires, O. (2009). The emerging role of EpCAM in cancer and stem cell signaling. Cancer Res 69, 5627-5629. Munz, M., Kieu, C., Mack, B., Schmitt, B., Zeidler, R., and Gires, O. (2004). The carcinoma-associated antigen EpCAM upregulates c-myc and induces cell proliferation. Oncogene 23, 5748-5758. Okabe, M., Tsukahara, Y., Tanaka, M., Suzuki, K., Saito, S., Kamiya, Y., Tsujimura, T., Nakamura, K., and Miyajima, A. (2009). Potential hepatic stem cells reside in EpCAM+ cells of normal and injured mouse liver. Development 136, 1951-1960. Paku, S., Schnur, J., Nagy, P., and Thorgeirsson, S.S. (2001). Origin and Structural Evolution of the Early Proliferating Oval Cells in Rat Liver. The American Journal of Pathology 158, 1313-1323. Preisegger, K.H., Factor, V.M., Fuchsbichler, A., Stumptner, C., Denk, H., and Thorgeirsson, S.S. (1999). Atypical ductular proliferation and its inhibition by transforming growth factor beta1 in the 3,5-diethoxycarbonyl-1,4-dihydrocollidine mouse model for chronic alcoholic liver disease. Laboratory investigation; a journal of technical methods and pathology 79, 103-109. Ralhan, R. (2010). EpCAM nuclear localization identifies aggressive thyroid cancer and is a marker for poor prognosis. BMC Cancer. Reya, T., Duncan, A.W., Ailles, L., Domen, J., Scherer, D.C., Willert, K., Hintz, L., Nusse, R., and Weissman, I.L. (2003). A role for Wnt signalling in self-renewal of haematopoietic stem cells. Nature 423, 409-414. Roskams, T.A., Theise, N.D., Balabaud, C., Bhagat, G., Bhathal, P.S., Bioulac-Sage, P., Brunt, E.M., Crawford, J.M., Crosby, H.A., Desmet, V., et al. (2004). Nomenclature of the finer branches of the biliary tree: canals, ductules, and ductular reactions in human livers. Hepatology 39, 1739-1745. Rountree, C.B., Barsky, L., Ge, S., Zhu, J., Senadheera, S., and Crooks, G.M. (2007). A CD133-expressing murine liver oval cell population with bilineage potential. Stem Cells 25, 2419-2429. Schmelzer, E., Wauthier, E., and Reid, L.M. (2006). The phenotypes of pluripotent human hepatic progenitors. Stem Cells 24, 1852-1858. Schnell, U., Cirulli, V., and Giepmans, B.N. (2013). EpCAM: structure and function in health and disease. Biochim Biophys Acta 1828, 1989-2001. Sekine, S., Gutierrez, P.J., Lan, B.Y., Feng, S., and Hebrok, M. (2007). Liver-specific loss of beta-catenin results in delayed hepatocyte proliferation after partial hepatectomy. Hepatology 45, 361-368. Sekiya, S., and Suzuki, A. (2012). Intrahepatic cholangiocarcinoma can arise from Notch-mediated conversion of hepatocytes. J Clin Invest 122, 3914-3918. Sekiya, S., and Suzuki, A. (2014). Hepatocytes, rather than cholangiocytes, can be the major source of primitive ductules in the chronically injured mouse liver. Am J Pathol 184, 1468-1478. Semenza, G.L. (2007). Hypoxia-inducible factor 1 (HIF-1) pathway. Sci STKE. Spee, B., Carpino, G., Schotanus, B.A., Katoonizadeh, A., Vander Borght, S., Gaudio, E., and Roskams, T. (2010). Characterisation of the liver progenitor cell niche in liver diseases: potential involvement of Wnt and Notch signalling. Gut 59, 247-257. Tag, C.G., Sauer-Lehnen, S., Weiskirchen, S., Borkham-Kamphorst, E., Tolba, R.H., Tacke, F., and Weiskirchen, R. (2015). Bile duct ligation in mice: induction of inflammatory liver injury and fibrosis by obstructive cholestasis. J Vis Exp. Takase, H.M., Itoh, T., Ino, S., Wang, T., Koji, T., Akira, S., Takikawa, Y., and Miyajima, A. (2013). FGF7 is a functional niche signal required for stimulation of adult liver progenitor cells that support liver regeneration. Genes Dev 27, 169-181. Tarlow, B.D., Pelz, C., Naugler, W.E., Wakefield, L., Wilson, E.M., Finegold, M.J., and Grompe, M. (2014). Bipotential adult liver progenitors are derived from chronically injured mature hepatocytes. Cell Stem Cell 15, 605-618. Thompson, M.D., and Monga, S.P. (2007). WNT/beta-catenin signaling in liver health and disease. Hepatology 45, 1298-1305. Tirnitz-Parker, J.E., Viebahn, C.S., Jakubowski, A., Klopcic, B.R., Olynyk, J.K., Yeoh, G.C., and Knight, B. (2010). Tumor necrosis factor-like weak inducer of apoptosis is a mitogen for liver progenitor cells. Hepatology 52, 291-302. Trzpis, M., McLaughlin, P.M., van Goor, H., Brinker, M.G., van Dam, G.M., de Leij, L.M., Popa, E.R., and Harmsen, M.C. (2008). Expression of EpCAM is up-regulated during regeneration of renal epithelia. J Pathol 216, 201-208. van der Gun, B.T., de Groote, M.L., Kazemier, H.G., Arendzen, A.J., Terpstra, P., Ruiters, M.H., McLaughlin, P.M., and Rots, M.G. (2011). Transcription factors and molecular epigenetic marks underlying EpCAM overexpression in ovarian cancer. Br J Cancer 105, 312-319. Wang, G.L., Jiang, B.H., Rue, E.A., and Semenza, G.L. (1995). Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci U S A. Weber, L.W., Boll, M., and Stampfl, A. (2003). Hepatotoxicity and mechanism of action of haloalkanes: carbon tetrachloride as a toxicological model. Crit Rev Toxicol 33, 105-136. Yamada, S., Utsunomiya, T., Morine, Y., Imura, S., Ikemoto, T., Arakawa, Y., Kanamoto, M., Iwahashi, S., Saito, Y., Takasu, C., et al. (2014). Expressions of hypoxia-inducible factor-1 and epithelial cell adhesion molecule are linked with aggressive local recurrence of hepatocellular carcinoma after radiofrequency ablation therapy. Ann Surg Oncol 21 Suppl 3, S436-442. Yamashita, T., Budhu, A., Forgues, M., and Wang, X.W. (2007). Activation of hepatic stem cell marker EpCAM by Wnt-beta-catenin signaling in hepatocellular carcinoma. Cancer Res 67, 10831-10839. Yamashita, T., Forgues, M., Wang, W., Kim, J.W., Ye, Q., Jia, H., Budhu, A., Zanetti, K.A., Chen, Y., Qin, L.X., et al. (2008). EpCAM and alpha-fetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma. Cancer Res 68, 1451-1461. Yamashita, T., Ji, J., Budhu, A., Forgues, M., Yang, W., Wang, H.Y., Jia, H., Ye, Q., Qin, L.X., Wauthier, E., et al. (2009). EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features. Gastroenterology 136, 1012-1024. Yanger, K., and Stanger, B.Z. (2011). Facultative stem cells in liver and pancreas: fact and fancy. Dev Dyn 240, 521-529. Yanger, K., Zong, Y., Maggs, L.R., Shapira, S.N., Maddipati, R., Aiello, N.M., Thung, S.N., Wells, R.G., Greenbaum, L.E., and Stanger, B.Z. (2013). Robust cellular reprogramming occurs spontaneously during liver regeneration. Genes Dev 27, 719-724. Yimlamai, D., Christodoulou, C., Galli, G.G., Yanger, K., Pepe-Mooney, B., Gurung, B., Shrestha, K., Cahan, P., Stanger, B.Z., and Camargo, F.D. (2014). Hippo pathway activity influences liver cell fate. Cell 157, 1324-1338. Yoon, S.M., Gerasimidou, D., Kuwahara, R., Hytiroglou, P., Yoo, J.E., Park, Y.N., and Theise, N.D. (2011). Epithelial cell adhesion molecule (EpCAM) marks hepatocytes newly derived from stem/progenitor cells in humans. Hepatology 53, 964-973. Zhang, Q., Bai, X., Chen, W., Ma, T., Hu, Q., Liang, C., Xie, S., Chen, C., Hu, L., Xu, S., et al. (2013). Wnt/beta-catenin signaling enhances hypoxia-induced epithelial-mesenchymal transition in hepatocellular carcinoma via crosstalk with hif-1alpha signaling. Carcinogenesis 34, 962-973. Zhou, F.Q., Qi, Y.M., Xu, H., Wang, Q.Y., Gao, X.S., and Guo, H.G. (2015). Expression of EpCAM and Wnt/ beta-catenin in human colon cancer. Genet Mol Res 14, 4485-4494. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/78138 | - |
dc.description.abstract | 肝臟具有很好的再生能力,當受到損傷時會開啟其修復機制,並且會依據損傷的種類而使用不同的方式進行修復。過去研究發現慢性肝損傷之下的修復方式,會藉由肝前驅細胞的形成及擴增,以分化出新的細胞。但肝臟對於慢性肝損傷的修復機制仍然需要更深入的探討。
我們過去研究中發現四氯化碳所誘導的慢性肝損傷中,因為肝纖維化的形成,會導致肝臟內部缺氧,使得細胞表現 HIF-1α。另外也發現這些細胞會同時具有 EpCAM 與 CK19 的表現,顯示它們可能為肝前驅細胞。不過目前對於這些肝前驅細胞形成的機制以及它的細胞來源並不清楚,由於這些肝前驅細胞產生的位置在中央靜脈 (central vein) 附近,我們猜測可能是由成熟肝細胞退分化而來。 在本研究中,我想要探討低氧環境是否會使得肝細胞退分化 (dedifferentiation) 為肝前驅細胞。首先利用肝臟灌流 (liver perfusion) 的方式將小鼠的肝細胞分離出來,並培養在低氧環境之下。實驗結果顯示肝細胞在低氧環境之下,會表現肝前驅細胞的標記分子 EpCAM 與 CK19。另外,與幹細胞特性相關的分子 Sox2 與 Nanog 也有增加的現象,證實肝細胞在低氧環境之下,的確能夠被誘導退分化為肝前驅細胞。接著,實驗結果也顯示肝細胞於低氧環境之下,會開啟一個對於調控幹細胞特性相當重要的訊息傳導路徑,稱作 Wnt 訊息傳導路徑。最後也證實了 HIF-1α 可以增強 EpCAM 的轉錄活性。 綜合以上結果,低氧環境之下,HIF-1α 可以藉由開啟 Wnt 訊息傳導路徑 以及調控 EpCAM 的表現,將肝細胞「退分化」為肝前驅細胞,以幫助肝臟的再生。 | zh_TW |
dc.description.abstract | Liver possesses great regeneration ability, making it enable to regenerate when encountering injury. Different regeneration models exist based on the causes of injury. In the case of chronic liver injury, liver progenitor cells (LPCs) can be activated and proliferate in order to produce new cells during regeneration. However, the mechanism of liver regeneration during chronic liver injury remains to be clarified.
During CCl4-induced chronic liver injury, it was found that liver fibrosis would lead to hypoxia and some liver cells would express HIF-1α. Besides, these HIF-1α-positive cells also expressed EpCAM and CK19, suggesting that they were LPCs. However, the mechanisms of LPCs generation and their origin cells are still controversial. Since these LPCs were detected around central vein, we hypothesized that they were de-differentiated from mature hepatocytes. In this study, I investigated whether hepatocytes can de-differentiate into LPCs under hypoxia. First, primary hepatocytes were isolated from mice using liver perfusion and cultured under hypoxic conditions. Under hypoxia, primary hepatocytes expressed LPC markers such as EpCAM and CK19. Furthermore, stemness markers including Sox2 and Nanog were also elevated. Thus, hepatocytes could de-differentiate into LPCs under hypoxia. In addition, hepatocytes cultured under hypoxia could activate Wnt signaling, which is one of the essential signaling for stemness regulation. At last, I found that HIF-1α could enhance the transcription activity of EpCAM. In summary, under hypoxia, HIF-1α could activate Wnt signaling and regulate the expression of EpCAM, which might contribute to de-differentiation of hepatocytes into LPCs and promote liver regeneration. | en |
dc.description.provenance | Made available in DSpace on 2021-07-11T14:43:28Z (GMT). No. of bitstreams: 1 ntu-105-R03b22034-1.pdf: 2366036 bytes, checksum: 6dbf44f27f875a90bd4d471f531306fb (MD5) Previous issue date: 2016 | en |
dc.description.tableofcontents | 口試委員審定書…………………………………………………………………………i
Acknowledgement……………………………………………………………………….ii Abstract…………………………………………………………………….…………...iii 中文摘要………………………………………………………………………………...v Table of Contents………………………………………………………………………..vi Chapter 1. Introduction………………………………………………………………...1 1.1 Liver injury and regeneration…………………………………………………1 1.1.1 The functions of liver…………………………………………………….1 1.1.2 Liver injury and regeneration mechanisms……………………………....1 1.2 Liver progenitors cell (LPC)………………………………………………….3 1.2.1 LPC and its role in liver regeneration……………………………………3 1.2.2 Signaling pathways promoting LPC activation and expansion…………...3 1.2.3 LPC origin………………………………………………………………..4 1.3 Hypoxia and Hypoxia-inducible factor 1 (HIF-1)……………………………6 1.3.1 Hypoxia and HIF-1………………………………………………………6 1.3.2 HIF-1α in liver diseases………………………………………………….7 1.3.3 Fibrosis-induced hypoxia and LPC activation…………………………..11 1.4 Wnt/β-catenin signaling pathway…………………………………………....14 1.4.1 Wnt/β-catenin signaling pathway……………………………………….14 1.4.2 Wnt/β-catenin signaling in liver disease………………………………...16 1.4.3 HIF-1α and Wnt/β-catenin signaling……………………………………16 1.5 Epithelial cell adhesion molecule (EpCAM)………………………………...17 1.5.1 Epithelial cell adhesion molecule (EpCAM)…………………………....17 1.5.2 EpCAM in liver disease………………………………………………....18 1.5.3 HIF-1α and EpCAM…………………………………………………….20 1.5.4 Crosstalk between Wnt/β-catenin and EpCAM…………………………20 Chapter 2. Motivation and Aim……………………………………………………….22 Chapter 3. Materials and Methods……………………………………………………23 3.1 Primary hepatocytes isolation and culture…………………………………...23 3.2 Cellular RNA extraction……………………………………………………..23 3.3 Quantitative reverse transcription polymerase chain reaction (qRTPCR)……24 3.4 Cellular protein extraction…………………………………………………...24 3.5 Western blotting……………………………………………………………..25 3.6 Cell immunofluorescence staining…………………………………………..26 3.7 Luciferase assay……………………………………………………………..26 3.8 Chromatin immunoprecipitation (ChIP)……………………………………..27 3.9 Image processing…………………………………………………………….28 3.10 Statistical analysis…………………………………………………………...29 Chapter 4. Results…………………………………………………………………….30 4.1 Hypoxia enhanced HIF-1α expression in primary hepatocytes…………..…..30 4.2 Hypoxia induced hepatocytes de-differentiation………………………….…30 4.3 HIF-1α enhanced EpCAM transcription activity…………………………….31 4.4 Hypoxia activated Wnt signaling in hepatocytes…………………………….32 Chapter 5. Discussion and Conclusion………………………………………………..34 Chapter 6. Figures and Tables………………………………………………………...40 Table 1. List of qPCR primers……………………………………………………40 Table 2. List of antibodies………………………………………………………..41 Figure 1. Confirmation of HIF-1α protein expression…………………………....42 Figure 2. Confirmation of hypoxic condition in primary hepatocyte by HIF-1α target gene expression……………………………………………………………...43 Figure 3. Hypoxia decreased the expression of mature hepatocyte marker in primary hepatocyte………………………………………………………………...44 Figure 4. Hypoxia increased the expression of LPC marker in primary hepatocyte………………………………………………………………………….45 Figure 5. Hypoxia increased the expression of stemness marker in primary hepatocyte………………………………………………………………………….46 Figure 6. Hypoxia altered the expression of mature hepatocyte marker and LPC marker in primary hepatocyte……………………………………………………...47 Figure 7. Hypoxia increased EpCAM and CK19 expression in primary hepatocyte………………………………………………………………………….48 Figure 8. HIF-1α enhances EpCAM transcription activity in HEK293T and Huh7……………………………………………………………………………….49 Figure 9. HIF-1α directly binds onto EpCAM promoter…………………………51 Figure 10. Hypoxia increased the expression of Wnt signaling target genes in primary hepatocyte in primary hepatocyte………………………………………....52 Chapter 7. Reference………………………………………………………………….53 | |
dc.language.iso | en | |
dc.title | 肝再生過程中低氧環境對於肝前驅細胞形成之分子解析 | zh_TW |
dc.title | The molecular mechanism of hepatic progenitor cells generation under liver injury-induced hypoxia | en |
dc.type | Thesis | |
dc.date.schoolyear | 104-2 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 趙曉梅,黃楓婷 | |
dc.subject.keyword | 肝前驅細胞,退分化,低氧,EpCAM,HIF,Wnt/β-catenin, | zh_TW |
dc.subject.keyword | LPC,de-differentiation,hypoxia,EpCAM,HIF,Wnt/β-catenin, | en |
dc.relation.page | 64 | |
dc.identifier.doi | 10.6342/NTU201602268 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2016-08-11 | |
dc.contributor.author-college | 生命科學院 | zh_TW |
dc.contributor.author-dept | 生化科技學系 | zh_TW |
顯示於系所單位: | 生化科技學系 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-105-R03b22034-1.pdf 目前未授權公開取用 | 2.31 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。